CBD has shown promise in eliminating certain bacteria because it interacts with the endocannabinoid system. And with these encouraging outcomes, the cannabinoid is making waves for its untapped potential.
To date, CBD has been widely studied for its anti-inflammatory and seizure-suppressant properties. In scientific testing, CBD has shown promise to be an effective treatment for acne, psoriasis — and even cancer.
Currently used for chronic pain, insomnia, and even relief from anxiety, new research shows CBD could pave the way for a new class of antibiotics. Researchers say CBD has the potential to be the first new class of antibiotics for resistant bacteria in over 50 years.
And with current antibiotic drugs having limited efficacy against bacteria and limited usage due to its toxicity for prolonged treatments, CBD is a solid option. Researchers say CBD has the potential to be the first new class of antibiotics for resistant bacteria in over 50 years.
How Might CBD Kill Bacteria?
CBD has been proven as a highly effective resource against Gram-positive bacteria, including the antibiotic-resistant pathogen MRSA (methicillin-resistant Staphylococcus aureus).
The popular cannabinoid demonstrated the ability to break down biofilms — slimy accumulation of bacteria. These biofilms help MRSA survive against antibiotics.
New research indicates that CBD proves so effective because it can burst the outer cell membranes of bacteria.
Study Reveals CBD Effective Against Bacteria
Researchers at the University of Queensland believe CBD could lead to the first new class of antibiotics for resistant bacteria as published in Communications Biology. The study was funded by Botanix Pharmaceuticals Ltd., which is researching uses of CBD for skin conditions.
Mark Blaskovich, an associate professor at the University of Queensland Institute for Molecular Bioscience, stated CBD seems particularly efficient against Gram-negative bacteria that current antibiotics have a challenging time overriding.
“CBD showed a low tendency to cause resistance in bacteria even when we sped up potential development by increasing concentrations of the antibiotic during ‘treatment’. We looked at how quickly the CBD killed the bacteria. It’s quite fast, within 3 hours, which is pretty good. Vancomycin (Vancocin) kills over 6 to 8 hours. Now we have established that cannabidiol is effective against these Gram-negative bacteria, we are looking at its mode of action, improving its activity and finding other similar molecules to open up the way for a new class of antibiotics.” stated Blaskovich.